Revelation Biosciences, Inc. 8-K Report: Key Financial Insights & Stock Details

The provided section of the financial report contains key information regarding Revelation Biosciences, Inc. Here are the most important insights extracted from the data:

Company Identification:

Name: Revelation Biosciences, Inc.
CIK: 0001810560
SEC Filing Type: 8-K
SEC Central Index Key (CIK): 0001810560
Address: 4660 La Jolla Village Drive, Suite 100, San Diego, CA 92122
Contact Number: (650) 800-3717

Common Stock Information:

Type: Common stock
Par Value: $0.001 per share
Ticker Symbol: REVB
Exchange: NASDAQ

Redeemable Warrants Information:

Type: Redeemable warrants
Exercisable for: Each warrant is exercisable for a 1/16,800th share of common stock.
Exercise Price: $193,200.00 per share
Ticker Symbol: REVBW
Exchange: NASDAQ

Filing Dates:

Report Date: February 19, 2025
Context Period: The financial data is relevant for the period starting and ending on February 19, 2025.

Document Structure:

The report is structured using XBRL (eXtensible Business Reporting Language), which is a standardized format for financial reporting.

Defined Contexts:

There are several defined contexts, specifying the periods and segments related to the common stock and redeemable warrants.

Summary:

Revelation Biosciences, Inc. is filing an 8-K report detailing its financial instruments, including common stock and redeemable warrants, with specific terms outlined for each type of security. The report is relevant for investors and stakeholders as of February 19, 2025, and is filed under regulatory compliance with the SEC.